IFRX
IFRX
NASDAQ · Biotechnology

Inflarx Nv

$0.89
+0.06 (+7.54%)
As of Mar 31, 10:12 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 11 79%
Hold 3 21%
Sell 0 0%
Price Target
Analyst Price Target +570.8% upside
Low Target $4.29
Average Target $6.00
High Target $7.91
Current Price $0.89
Current
$0.89
Target
$6.00
$4.29 $6.00 avg $7.91
Scenario Analysis
Bear Case
$4.29
379.7%
Low target
Base Case
$6.00
+570.8%
Avg target
Bull Case
$7.91
+784.4%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$1.94
-53.9% from high
52-Week Low
$0.71
+25.7% from low
Target vs 52W High
$6.00
+209.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%